These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9610106)

  • 1. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events.
    Kopp-Schneider A; Portier C; Bannasch P
    Math Biosci; 1998 Mar; 148(2):181-204. PubMed ID: 9610106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions.
    Burkholder I; Kopp-Schneider A
    Math Biosci; 2002; 179(2):145-60. PubMed ID: 12208613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells.
    Geisler I; Kopp-Schneider A
    Math Biosci; 2000 Dec; 168(2):167-85. PubMed ID: 11121564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multistage rodent hepatocarcinogenesis.
    Goldfarb S; Pugh TD
    Prog Liver Dis; 1986; 8():597-620. PubMed ID: 3520671
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic analysis of multistage hepatocarcinogenesis.
    Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
    Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
    [No Abstract]   [Full Text] [Related]  

  • 6. Concepts in multistage carcinogenesis.
    Ito N; Hasegawa R; Imaida K; Hirose M; Asamoto M; Shirai T
    Crit Rev Oncol Hematol; 1995 Nov; 21(1-3):105-133. PubMed ID: 8822499
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene amplification during stages of carcinogenesis.
    Locker J
    Basic Life Sci; 1991; 57():157-66; discussion 166-70. PubMed ID: 1814281
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S; Merlino GT; Ward JM
    Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis.
    Kowalik MA; Sulas P; Ledda-Columbano GM; Giordano S; Columbano A; Perra A
    Oncotarget; 2015 Nov; 6(36):38749-63. PubMed ID: 26452031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation and apoptosis in normal liver and preneoplastic foci.
    Schulte-Hermann R; Bursch W; Kraupp-Grasl B; Oberhammer F; Wagner A; Jirtle R
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):87-90. PubMed ID: 8013429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No enhancement by phenobarbital of the hepatocarcinogenicity of a choline-devoid diet in the rat.
    Saito R; Chandar N; Janosky JE; Lombardi B
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):197-207. PubMed ID: 2396046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compared promoting potential of D-galactosamine, carbon tetrachloride and partial hepatectomy in rapid induction of preneoplastic liver lesions in the rat.
    Tsuda H; Masui T; Ikawa E; Imaida K; Ito N
    Cancer Lett; 1987 Oct; 37(2):163-71. PubMed ID: 3677052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent and remodeling hepatic preneoplastic lesions present differences in cell proliferation and apoptosis, as well as in p53, Bcl-2 and NF-kappaB pathways.
    Mazzantini RP; de Conti A; Moreno FS
    J Cell Biochem; 2008 Feb; 103(2):538-46. PubMed ID: 17546582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
    Dragan YP; Hully J; Crow R; Mass M; Pitot HC
    Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.
    Moolgavkar SH; Luebeck EG; de Gunst M; Port RE; Schwarz M
    Carcinogenesis; 1990 Aug; 11(8):1271-8. PubMed ID: 2143703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the stage of progression in hepatocarcinogenesis in the rat.
    Pitot HC
    Basic Life Sci; 1991; 57():3-18. PubMed ID: 1814289
    [No Abstract]   [Full Text] [Related]  

  • 17. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic instability occurs sooner than expected: promotion, progression and clonality during hepatocarcinogenesis in the rat.
    Sudilovsky O; Hinrichsen LI; Hei TK; Whitacre CM; Wang JH; Kasturi S; Jiang SH; Cechner R; Miron S; Abdul-Karim F
    Basic Life Sci; 1991; 57():263-77. PubMed ID: 1667572
    [No Abstract]   [Full Text] [Related]  

  • 19. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
    Goldfarb S; Pugh TD; Koen H; He YZ
    Environ Health Perspect; 1983 Apr; 50():149-61. PubMed ID: 6873010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
    Pitot HC; Dragan Y; Sargent L; Xu YH
    Environ Health Perspect; 1991 Jun; 93():181-9. PubMed ID: 1723043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.